BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update

  March 5, 2026

   · 

  9 min read
• Press Releases

  CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

  March 5, 2026

   · 

  5 min read
• Press Releases

  NexCure, Inc. Launches with $19 Million Series A Financing to enable CAR-T and other advanced treatment delivery in community outpatient settings

  March 5, 2026

   · 

  6 min read
• Press Releases

  Zevra Therapeutics Appoints Justin Renz as Chief Financial Officer

  March 5, 2026

   · 

  3 min read
• Press Releases

  Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences

  March 5, 2026

   · 

  9 min read
• Press Releases

  SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI

  March 5, 2026

   · 

  9 min read
• Press Releases

  Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences

  March 5, 2026

   · 

  3 min read
• Press Releases

  Collegium to Present New Real-World Data at PainConnect 2026

  March 5, 2026

   · 

  11 min read
• Press Releases

  Galimedix Therapeutics to present promising pre-clinical data with next generation oral amyloid beta aggregation modulator at AD/PD™ 2026 Conference

  March 5, 2026

   · 

  3 min read
• Press Releases

  Kestrel Therapeutics Announces IND Clearance by U.S. FDA of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, Enabling Initiation of Phase 1 Trial

  March 5, 2026

   · 

  2 min read